Jean P A, Roth R A
Department of Pharmacology and Toxicology, Michigan State University, East Lansing 48824-1317, USA.
Biochem Pharmacol. 1995 Oct 26;50(9):1469-74. doi: 10.1016/0006-2952(95)02051-9.
1-Naphthylisothiocyanate (ANIT), but not 2-naphthylisothiocyanate (BNIT), produces cholangiolitic hepatitis in rats after a single, oral administration. The mechanisms responsible for the disparate toxic outcomes for these closely related structural isomers are not fully understood. Recent reports suggest that ANIT-induced hepatotoxicity is dependent upon the formation and biliary excretion of a reversible glutathione-ANIT conjugate. To understand better the relationship between hepatic glutathione, secretion into bile and hepatotoxicity, the bile concentrations and hepatotoxicities of ANIT and BNIT were examined in rats with and without pretreatment with buthionine sulfoximine (BSO). ANIT (100 mg/kg, p.o.) caused a 3-fold elevation of plasma alanine aminotransferase activity (ALT), a 6-fold elevation of total plasma bilirubin, and a > 90% reduction in bile flow 24 hr after administration. BNIT, at this same dose and route of administration, did not alter significantly these markers of liver injury. Accumulation of ANIT and BNIT in bile occurred with the same temporal characteristics; however, BNIT accumulated to markedly larger concentrations (292 +/- 83 and 235 +/- 100 microM BNIT and 78 +/- 19 and 29 +/- 13 microM ANIT at 1 and 4 hr, respectively). The accumulation of ANIT and BNIT in bile was coincident with a > 2-fold elevation of reduced glutathione in bile. Pretreatment of rats with BSO decreased hepatic glutathione concentration and reduced the concentration of naphthylisothiocyanates in bile by 85%. Associated with this reduction was an attenuation of ANIT hepatotoxicity. Altogether, these findings indicate that both ANIT and BNIT accumulate in bile in a glutathione-dependent manner, yet they yield different hepatotoxic outcomes. Therefore, the disparity in hepatotoxicities observed with these isomers is not related to a difference in ability to enter bile. Other differences, such as in metabolism, chemical reactivity, conjugate stability and/or cytotoxic potential to bile duct epithelial cells may be more important determinants of hepatotoxicity.
单次口服1-萘基异硫氰酸酯(ANIT)可在大鼠中引发胆管炎性肝炎,但2-萘基异硫氰酸酯(BNIT)则不会。对于这些结构紧密相关的同分异构体产生不同毒性结果的机制尚未完全明确。近期报告表明,ANIT诱导的肝毒性依赖于可逆性谷胱甘肽-ANIT共轭物的形成及胆汁排泄。为了更好地理解肝脏谷胱甘肽、胆汁分泌与肝毒性之间的关系,我们检测了在有或没有用丁硫氨酸亚砜胺(BSO)预处理的大鼠中ANIT和BNIT的胆汁浓度及肝毒性。给予ANIT(100mg/kg,口服)后24小时,血浆丙氨酸转氨酶活性(ALT)升高了3倍,总血浆胆红素升高了6倍,胆汁流量减少了90%以上。相同剂量和给药途径的BNIT并未显著改变这些肝损伤指标。ANIT和BNIT在胆汁中的蓄积具有相同的时间特征;然而,BNIT蓄积到明显更高的浓度(1小时和4小时时分别为292±83和235±100μM BNIT以及78±19和29±13μM ANIT)。ANIT和BNIT在胆汁中的蓄积与胆汁中还原型谷胱甘肽升高2倍以上同时发生。用BSO预处理大鼠可降低肝脏谷胱甘肽浓度,并使胆汁中萘基异硫氰酸酯的浓度降低85%。伴随着这种降低的是ANIT肝毒性的减弱。总之,这些发现表明ANIT和BNIT均以谷胱甘肽依赖的方式在胆汁中蓄积,但它们产生不同的肝毒性结果。因此,观察到的这些异构体肝毒性差异与进入胆汁的能力差异无关。其他差异,如代谢、化学反应性、共轭物稳定性和/或对胆管上皮细胞的细胞毒性潜力,可能是肝毒性更重要的决定因素。